1177 — Sino Biopharmaceutical Share Price
0.000.00%
Last trade - 00:00- HK$72.08bn
- HK$78.38bn
- CNY28.87bn
- 96
- 34
- 90
- 88
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.36 | ||
| PEG Ratio (f) | 2.73 | ||
| EPS Growth (f) | 8.49% | ||
| Dividend Yield (f) | 1.63% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.18 | ||
| Price to Tang. Book | 2.41 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.41 | ||
| EV to EBITDA | 10.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.32% | ||
| Return on Equity | 6.15% | ||
| Operating Margin | 17.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 23,647.22 | 26,861.36 | 26,026.16 | 26,199.41 | 28,866.16 | 32,110.44 | 35,260.61 | 3.56% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -0.16 | +417.98 | -87.25 | +3.98 | +55.16 | +6.47 | +12.57 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is principally engaged in the related medical and hospital business.
Directors
- Y Y Tse CHM (28)
- Yi Li CEO (59)
- Cheung Ling Cheng VCH (57)
- Ping Tse VCH (69)
- Jiayin Ma CFO (45)
- Hsin Tse SVP (51)
- Mingqin Li SVP (62)
- Minggang Wang VPR (64)
- Yangsheng Chen VPR (53)
- Wenjun Geng VPR (50)
- Qian Li VPR (41)
- Ren Li VPR (48)
- Songwu Lu VPR (58)
- Ling Yang VPR (53)
- Zhoushan Tian GMG (57)
- Wenyu Xia GMG (52)
- Wei Nong Ye GMG (58)
- Yong Zhu GMG (54)
- Haihua Liu DGM (57)
- Kuanqi Wang DGM (54)
- Ling Zhang DGM (47)
- Yangqing Zhang DGM (52)
- Zhenqian Zhang DGM (51)
- Chunxia Zhu DGM (44)
- Yongqiang Zhu DGM (44)
- Chau Ling Yu CTR (52)
- S Y Tse EDR (25)
- Shanchun Wang EDR (53)
- Shanhai Cao OTH (50)
- Haiyan Chen OTH (52)
- Qishun Hu OTH (58)
- Yujing Liu OTH (55)
- Zong Liu OTH (56)
- Hongqi Wang OTH (55)
- Yong Yang OTH (48)
- Hailiang Zhao OTH (42)
- Yanping Zhao OTH (39)
- Yaojie Zhu OTH (51)
- Oi Nin Chan SEC (53)
- Dakui Li NID (77)
- Kwok Tung Li NID (66)
- Hong Lu NID (51)
- Zhengfei Lu NID (58)
- Lu Fu Zhang NID (64)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 2nd, 2000
- Public Since
- December 8th, 2003
- No. of Employees
- 24,379
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 18,769,717,230
- Address
- Unit 09, 41F, Office Tower
- Web
- https://www.sinobiopharm.com/
- Phone
- +852 null28029886
- Auditors
- Ernst & Young
Upcoming Events for 1177
Dividend For 1177.HK - 0.0400 HKD
Half Year 2025 Sino Biopharmaceutical Ltd Earnings Release
Similar to 1177
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Sino Biopharmaceutical share price?
As of Today at 23:16 UTC, shares in Sino Biopharmaceutical are trading at HK$3.95. This share price information is delayed by 15 minutes.
How has the Sino Biopharmaceutical share price performed this year?
Shares in Sino Biopharmaceutical last closed at HK$3.95 and the price had moved by +44.16% over the past 365 days. In terms of relative price strength the Sino Biopharmaceutical share price has outperformed the FTSE Developed Asia Pacific Index by +45.81% over the past year.
What are the analyst and broker recommendations for Sino Biopharmaceutical?
The overall consensus recommendation for Sino Biopharmaceutical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sino Biopharmaceutical dividend yield?
The Sino Biopharmaceutical dividend yield is 1.77% based on the trailing twelve month period.
Does Sino Biopharmaceutical pay a dividend?
Last year, Sino Biopharmaceutical paid a total dividend of CNY0.07, and it currently has a trailing dividend yield of 1.77%.Looking ahead, shares in Sino Biopharmaceutical are due to go ex-dividend on 2025-06-16 and the next dividend pay date is 2025-07-10.
When does Sino Biopharmaceutical next pay dividends?
Sino Biopharmaceutical are due to go ex-dividend on 2025-06-16 and the next dividend pay date is 2025-07-10. The historic dividend yield on Sino Biopharmaceutical shares is currently 1.77%.
How do I buy Sino Biopharmaceutical shares?
To buy shares in Sino Biopharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sino Biopharmaceutical?
As of the previous close price of HK$3.95, shares in Sino Biopharmaceutical had a market capitalisation of HK$72.08bn.
Where are Sino Biopharmaceutical shares listed?
Here are the trading details for Sino Biopharmaceutical:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1177
What kind of share is Sino Biopharmaceutical?
Based on an overall assessment of its quality, value and momentum Sino Biopharmaceutical is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sino Biopharmaceutical share price forecast for 2025?
The analyst consensus target price for shares in Sino Biopharmaceutical is HK$4.85. That is 22.81% above the last closing price of HK$3.95.
Analysts covering Sino Biopharmaceutical currently have a consensus Earnings Per Share (EPS) forecast of CNY0.17 for the next financial year.
Find out moreWhat is the trend in the Sino Biopharmaceutical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sino Biopharmaceutical. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +18.24%.
As of the last closing price of HK$3.95, shares in Sino Biopharmaceutical were trading +20.57% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sino Biopharmaceutical PE Ratio?
The Sino Biopharmaceutical PE ratio based on its reported earnings over the past 12 months is 21.36. The shares last closed at HK$3.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sino Biopharmaceutical?
Sino Biopharmaceutical's management team is headed by:
- Y Y Tse - CHM
- Yi Li - CEO
- Cheung Ling Cheng - VCH
- Ping Tse - VCH
- Jiayin Ma - CFO
- Hsin Tse - SVP
- Mingqin Li - SVP
- Minggang Wang - VPR
- Yangsheng Chen - VPR
- Wenjun Geng - VPR
- Qian Li - VPR
- Ren Li - VPR
- Songwu Lu - VPR
- Ling Yang - VPR
- Zhoushan Tian - GMG
- Wenyu Xia - GMG
- Wei Nong Ye - GMG
- Yong Zhu - GMG
- Haihua Liu - DGM
- Kuanqi Wang - DGM
- Ling Zhang - DGM
- Yangqing Zhang - DGM
- Zhenqian Zhang - DGM
- Chunxia Zhu - DGM
- Yongqiang Zhu - DGM
- Chau Ling Yu - CTR
- S Y Tse - EDR
- Shanchun Wang - EDR
- Shanhai Cao - OTH
- Haiyan Chen - OTH
- Qishun Hu - OTH
- Yujing Liu - OTH
- Zong Liu - OTH
- Hongqi Wang - OTH
- Yong Yang - OTH
- Hailiang Zhao - OTH
- Yanping Zhao - OTH
- Yaojie Zhu - OTH
- Oi Nin Chan - SEC
- Dakui Li - NID
- Kwok Tung Li - NID
- Hong Lu - NID
- Zhengfei Lu - NID
- Lu Fu Zhang - NID